Tag: NLM

From clinical trials to daily practice: how to adequately administer sulbactam-durlobactam? alone or combined with imipenem?

doi: 10.1097/QCO.0000000000001148. Online ahead of print. Affiliations Expand Affiliations 1 Infectious Diseases Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna. 2 Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy. Item in Clipboard Cecilia Bonazzetti et al. Curr Opin Infect Dis. 2025. Show details Display options Display options Format AbstractPubMedPMID doi: 10.1097/QCO.0000000000001148. Online ahead of print. […]

How to Use Imaging: Cardiac Sarcoidosis

Review doi: 10.1161/CIRCIMAGING.125.017693. Online ahead of print. Affiliations Expand Affiliation 1 Division of Cardiovascular Medicine and Cardiovascular Imaging Program, Brigham and Women’s Hospital, Boston, Massachusetts; Harvard Medical School. Item in Clipboard Review Sanjay Divakaran. Circ Cardiovasc Imaging. 2025. Show details Display options Display options Format AbstractPubMedPMID doi: 10.1161/CIRCIMAGING.125.017693. Online ahead of print. Affiliation 1 Division […]

Deltoid ligament injuries: When and how to repair

Purpose: This study aims to illustrate the assessment and treatment strategies of acute and chronic deltoid ligament injuries, providing a treatment algorithm for each scenario. Methods: A retrospective review was conducted on 39 patients, who had either an acute deltoid ligament injury or suffered chronic deltoid ligament insufficiency. All patients were operated on between January […]

Improving the tolerability of antiseizure medications: When and how to use cenobamate and other new antiseizure medications

Despite the introduction of newer antiseizure medications (ASMs) with improved safety profiles over the past several years, rates of treatment-related intolerable adverse events (AEs) for people with epilepsy have not changed substantially. Tolerability issues can potentially jeopardize optimal dosing and effectiveness, regimen adherence, and treatment retention with these newer medications. Long-term clinical studies, open-label extension […]